Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Please confirm action

You are done for today with this topic.

Would you like to start learning session with this topic items scheduled for future?

Updated: Dec 28 2021

Mixed Connective Tissue Disorder (MCTD)

  • Snapshot
    • A 29-year-old woman presents with general malaise, myalgias, and low-grade fever. She also reports the tips of her fingers turn blue after touching a cold object, which subsequently returns to its baseline color when the cold object is no longer touched. On physical exam, there is a malar rash, swelling of the digits, and joint tenderness. Laboratory testing is positive for anti-nuclear antibodies (ANA) and anti-U1 RNP antibodies.
  • Introduction
    • Clinical definition
      • generalized connective tissue disorder with clinical features of systemic lupus erythematosus, systemic sclerodermia, and polymyositis
        • along with high levels of anti-U1-RNP antibodies
  • Epidemiology
    • Demographics
      • more common in women
      • 15-25 years of age but can occur at any age
  • ETIOLOGY
    • Pathophysiology
      • pathobiology
        • autoimmune disease
  • Presentation
    • Symptoms
      • Raynaud's phenomenon
      • arthralgia
      • arthritis
      • myositis
      • sclerodactyly
      • hand swelling
  • Imaging
    • Echocardiography
      • indications
        • for early diagnosis of pulmonary arterial hypertension and for the evaluation of valvular disease
  • Studies
    • Labs
      • positive for anti-U1-RNP antibodies
  • Differential
    • Systemic lupus erythematosus (SLE)
    • Scleroderma
    • Polymyositis
    • Rheumatoid arthritis
    • Idiopathic pulmonary arterial hypertension
  • DIAGNOSIS
    • Diagnostic criteria
      • clinical diagnosis supported by anti-U1-RNP antibodies on serology
  • Treatment
    • Treatment is aimed at controlling symptoms and is targeted at organ involvement
    • Medical
      • prednisone
        • indications
          • responsive in patients presenting with symptoms consistent with SLE
          • in patients with fatigue, myositis, myalgias, arthralgias, pleuritis, pericarditis, autoimmune anemia, and thrombocytopenia
      • calcium channel blockers
        • indications
          • pulmonary arterial hypertension
          • Raynaud's phenomenon
  • Complications
    • The major cause of death is pulmonary hypertension in MCTD
  • Prognosis
    • Generally a favorable outcome
Card
1 of 0
Question
1 of 1
Private Note